Therapeutics: Angiotensin II type 1 receptor (AGTR1)

Cancer

INDICATION: Pancreatic cancer

Patient sample and mouse studies suggest AGTR1 inhibitors could help sensitize obese pancreatic ductal adenocarcinoma (PDAC) patients

Read the full 192 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE